NIH-funded research R01 grant

How mouth bacteria resist saliva's natural oxidants and affect tooth decay

Official title: The impact of bacterial oxidative stress responses on the ecology and pathogenicity of oral streptococci

Funded at University of Alabama at Birmingham · NIH-11300219 · Data updated 2026-11-12

This work looks at how some common mouth bacteria protect themselves from a natural saliva chemical and how that may change the mix of bacteria linked to cavities.

More Oxidative Stress research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startMarch 10, 2025
Project endFebruary 28, 2030
Funding year2026
Award (this year)$369,201
NIH project number5R01DE034490-02
Project IDNIH-11300219 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants would include people with active dental cavities and people with healthy mouths who can provide saliva samples for comparing bacterial communities.

Less likely to help

People seeking immediate dental treatment or expecting direct personal health improvement are unlikely to receive clinical benefit from participating in this laboratory-focused research.

What this research studies

From a patient perspective, researchers will compare health-associated and cavity-associated Streptococcus bacteria to see why some survive better in human saliva. They will study a bacterial enzyme called RclA that can break down a saliva-made oxidant (HOSCN) and test how that enzyme changes bacterial survival in lab models. The team will run experiments that mix different bacterial species and expose them to saliva-like conditions to see which bacteria dominate. Results will be used to explain how bacterial defenses shape oral communities linked to tooth decay.

Why it matters

Potential benefit: If successful, this could point to new ways to prevent or reduce cavities by blocking bacterial defenses or promoting beneficial mouth bacteria.

How similar studies have gone: Previous research shows saliva produces the antimicrobial HOSCN and some bacteria resist it, but using the newly identified RclA enzyme to explain shifts in cavity-associated versus health-associated bacteria is a newer, less-tested idea.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Gray, Michael Jeffrey — University of Alabama at Birmingham
  • Study coordinator: Gray, Michael Jeffrey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.